Insulin in America: A Right or a Privilege?
Has Insulin Become a Privilege Rather Than a Right in America?
Despite Frederick Banting’s intention to make insulin freely available by selling the patent for just $1, insulin has become prohibitively expensive in the United States, with some patients paying over $300 per vial. This transformation of a life-saving medication from an affordable necessity to a luxury item represents a fundamental betrayal of the discoverer’s vision and raises critical questions about healthcare as a human right versus a market commodity.
